Venous thromboembolic complications in lymphoma patients
Lymphomas represent a heterogeneous group of malignant hematological diseases with high risk for development of venous thromboembolic complications (VTE). Consequently, VTE significantly impacts morbidity and mortality in these patients. Another concern is the financial burden of the healthcare syst...
Main Authors: | Otašević Vladimir, Antić Darko, Mihaljević Biljana |
---|---|
Format: | Article |
Language: | English |
Published: |
University of Belgrade, Medical Faculty
2020-01-01
|
Series: | Medicinski Podmladak |
Subjects: | |
Online Access: | https://scindeks-clanci.ceon.rs/data/pdf/0369-1527/2020/0369-15272004025O.pdf |
Similar Items
-
Cost-Effectiveness Analysis of Direct Oral Anticoagulants Versus Vitamin K Antagonists for Venous Thromboembolism in China
by: Ke-Xin Sun, et al.
Published: (2021-10-01) -
Characteristics and Predictors of Venous Thromboembolism Among Lymphoma Patients Undergoing Chemotherapy: A Cohort Study in China
by: Yue Chen, et al.
Published: (2022-05-01) -
Postoperative venous thromboembolism risk in patients with vulvar carcinoma: An analysis of the National surgical Quality Improvement Program (NSQIP) database
by: Quinn Kistenfeger, et al.
Published: (2024-08-01) -
The Saudi Consensus for the Management of Cancer-Associated Thromboembolism: A Modified Delphi-Based Study
by: Mohammed Alsheef, et al.
Published: (2023-01-01) -
Venous thromboembolism risk, prophylaxis and management in cancer patients with COVID-19: An unmet medical need
by: Benjamin Brenner, et al.
Published: (2022-03-01)